Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 117 of 144 pages ‹ First < 115 116 117 118 119 > Last ›
HSL197
Faint Warning Archives
CBC News 2004 Feb
HSL514
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb; 30:(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8
HSL1171
Drug costs: research and development costs: the great illusion
Prescrire Int 2004 Feb; 13:(69):32-6
HSL1786
Berman A.
Reducing medication errors through naming, labeling, and packaging.
J Med Syst 2004 Feb; 28:(1):9-29
HSL1788
Baylis F.
The Olivieri debacle: where were the heroes of bioethics?
J Med Ethics 2004 Feb; 30:(1):44-9
http://jme.bmjjournals.com/cgi/content/full/30/1/44
HSL2392
Ferris LE, Singer PA, Naylor CD.
Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto.
J Med Ethics 2004 Feb; 30:(1):25-9
http://jme.bmjjournals.com/cgi/content/full/30/1/25
HSL2393
Holmes DR Jr, Firth BG, James A, Winslow R, Hodgson PK, Gamble GL, Popp RL, Harrington RA.
Conflict of interest
Am Heart J 2004 Feb; 147:(2):228-37
HSL4631
Moss F, Thomson R.
A new structure for quality improvement reports.
Qual Saf Health Care 2004 Feb; 13:(1):6-7
http://qhc.bmjjournals.com/cgi/content/full/13/1/6?maxtoshow=&HITS=10&hits=1
HSL9686
Petersen E.
Malaria chemoprophylaxis: when should we use it and what are the options?
Expert Rev Anti Infect Ther 2004 Feb; 2:(1):119-32
HSL9784
Fung CH, Woo HE, Asch SM.
Controversies and legal issues of prescribing and dispensing medications using the Internet.
Mayo Clin Proc 2004 Feb; 79:(2):188-94
HSL97
Ives N .
Study from an F.D.A. critic argues that the agency is slow to police misleading pharmaceutical ads.
The New York Times 2004 Jan 30
http://www.nytimes.com/2004/01/30/business/media-business-advertising-study-fda-critic-argues-that-agency-slow-police.html?scp=99&sq=&st=nyt&pagewanted=print?pagewanted=all
HSL93
Vedantam , S .
Antidepressant Makers Withhold Data on Children
The Washington Post 2004 Jan 29
HSL94
Cassels , A .
Pressure to use newer, pricier drugs can give taxpayers heartburn
The Vancouver Sun 2004 Jan 29
HSL95
Siig , M .
Life After Lipitor: Is Pfizer product a quick fix or dangerous drug? Residents experience adverse reactions
Tahoe World 2004 Jan 29
HSL96
Vatican condemns Aids drug firms
BBC News 2004 Jan 29
http://news.bbc.co.uk/2/hi/europe/3442217.stm
HSL4475
Richards D.
Guess who’s coming to dinner
Australian Doctor Weekly 2004 Jan 29
HSL92
Swartz S.
FDA Big Factor Behind High US Drug Costs
Reuters 2004 Jan 28
http://www.biotechblog.com/2004/01/30/107549363617383245/
HSL91
Japsen B.
Ex-TAP sales manager found guilty: 1st to go to trial in Lupron probe
Chicago Tribune 2004 Jan 27
http://articles.chicagotribune.com/2004-01-27/business/0401270256_1_astrazeneca-plc-lupron-lahey-clinic
HSL90
Why Are Drugs So Expensive?
The American Progress Report 2004 Jan 26
HSL88
Critser G.
Truth: a Bitter Pill for Drug Makers
The LA Times 2004 Jan 25
http://articles.latimes.com/2004/jan/25/opinion/op-critser25
HSL89
Barnett A .
Revealed: how stars were hijacked to boost health company's profits
The Observer 2004 Jan 25
http://www.guardian.co.uk/uk/2004/jan/25/society.research
HSL86
Harris , G AND, M .
F.D.A. Begins Push to End Drug Imports
New York Times 2004 Jan 24
http://www.nytimes.com/2004/01/24/business/24mail.html?pagewanted=1
HSL87
Walsh , B .
Tauzin turns down Hollywood but weighs new offer: Drug industry may be wooing 13-term congressman
The Times 2004 Jan 24
HSL83
Studwell , J .
Oh, behave!
Financial Times 2004 Jan 23
HSL84
Shapiro D.
Drug Companies Get Too Close for Med School's Comfort
The New York Times 2004 Jan 20
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9F00E2D81439F933A15752C0A9629C8B63
HSL9787
Jacka M.
Mercenary hypocrisy at CMAJ.
CMAJ 2004 Jan 20; 170:(2):174
http://www.cmaj.ca/cgi/content/full/170/2/174-a
HSL2391
Jorgensen KJ, Gotzsche PC.
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.
BMJ 2004 Jan 17; 328:(7432):148
http://bmj.bmjjournals.com/cgi/content/full/328/7432/148
HSL193
Lee TH.
"Me-Too" Products — Friend or Foe?
N Engl J Med 2004 Jan 15; 350:(3):211-2
http://content.nejm.org/cgi/content/full/350/3/211
HSL3706
Burton B.
New Zealand moves to ban direct advertising of drugs.
BMJ 2004 Jan 10; 328:(7431):68
http://bmj.bmjjournals.com/cgi/content/full/328/7431/68-c
HSL9876
Hern JC.
Prescribing and dispensing of veterinary medicines.
Vet Rec 2004 Jan 10; 154:(2):60
HSL85
Pignarre P.
Health insurance: the bitter American lesson,
LE MONDE 2004 Jan 8
HSL2338
Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J.
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
JAMA 2004 Jan 7; 291:(1):54-62
http://jama.ama-assn.org/cgi/content/full/291/1/54
HSL9884
DeMaria AN.
Drug reimportation: sitting in the middle.
J Am Coll Cardiol 2004 Jan 7; 43:(1):149-50
http://linkinghub.elsevier.com/retrieve/pii/S0735109703014219
HSL9885
Austin PC, Mamdani MM, Tu K, Zwarenstein M.
Changes in prescribing patterns following publication of the ALLHAT trial.
JAMA 2004 Jan 7; 291:(1):44-5
http://jama.ama-assn.org/cgi/content/full/291/1/44
HSL1002
Gormley M.
Pfizer Settles Over Kids' Antibiotic Ads
Associated Press 2004 Jan 6
HSL1147
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-Jun; Suppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1
HSL1691
Cialdini RB, Goldstein NJ.
Social influence: compliance and conformity.
Annu Rev Psychol 2004; 55:591-621
http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.psych.55.090902.142015?cookieSet=1
HSL5316
Bell DS, Cretin S, Marken RS, Landman AB.
A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.
J Am Med Inform Assoc 2004 Jan-Feb 01; 11:(1):60-70
http://www.jamia.org/cgi/content/full/11/1/60
HSL20191
Glatter J
Promotion, Information and Advertising: Why Increasingly Blurred Boundaries do not Benefit the Public
Journal of Generic Medicines 2004 Jan 1; 1:(2):128-136
http://jgm.sagepub.com/content/1/2/128.abstract
HSL194
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship.
J Am Board Fam Pract 2004 Jan; 17:(1):6-18
http://www.jabfp.org/cgi/content/full/17/1/6
HSL356
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb; 73:(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010
HSL1138
Zoorob R, Larzelere M.
Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
J La State Med Soc 2004 Jan-Feb; 156:(1):28-32
HSL1150
Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S.
Physicians report on patient encounters involving direct-to-consumer advertising.
Health Aff (Millwood) 2004 Jan-Jun; Supplment Web Exclus:W4-219-33
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.219v1
HSL1155
Waxman HA.
Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
Health Aff (Millwood) 2004 Jan-Jun; Supplment Web Exclus:W4-256-8
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.256v1
HSL1167
Sumpradit N, Ascione FJ, Bagozzi RP.
A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
Clin Ther 2004 Jan; 26:(1):135-54
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4BSW890-G&_coverDate=01%2F31%2F2004&_alid=272329699&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=350cd528415b79ed8f6c00a62cff3cde
HSL1783
Bokhari SA.
How to become a biomedical (dental) journalist.
Saudi Med J 2004 Jan; 25:
HSL1787
Bennett WM.
Ethical conflicts for physicians treating ESRD patients.
Semin Dial 2004 Jan-Feb; 17:(1):1-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-139X.2004.17102.x?cookieSet=1
HSL1835
Keim S, Perina DG; CORD Board of Directors.
Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry.
Acad Emerg Med 2004 Jan; 11:(1):78
http://www.aemj.org/cgi/content/full/11/1/78
HSL1836
Keim SM, Mays MZ, Grant D.
Interactions between emergency medicine programs and the pharmaceutical industry.
Acad Emerg Med 2004 Jan; 11:(1):19-26
http://www.aemj.org/cgi/content/full/11/1/19
HSL2318
Hemminki E, Karttunen T, Hovi SL, Karro H.
The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Soc Sci Med 2004 Jan; 58:(1):89-97
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-48TM3V5-2&_coverDate=01%2F31%2F2004&_alid=307376484&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=be686b45176e3a6cf270c9e1dedc43b1
HSL2385
Friedman LS, Richter ED.
Relationship between conflicts of interest and research results.
J Gen Intern Med 2004 Jan; 19:(1):51-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2004.30617.x?cookieSet=1
HSL2386
Reinhardt UE.
Perspective: An information infrastructure for the pharmaceutical market.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):107-12
http://content.healthaffairs.org/cgi/content/full/23/1/107
HSL2387
Jeffords JM.
Direct-to-consumer drug advertising: you get what you pay for.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.253v1
HSL2388
Kelly P.
DTC advertising's benefits far outweigh its imperfections.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.246v1
HSL2389
Pitts , P. J.
Turning point or tipping point: new FDA draft guidances and the future of DTC advertising
Health Aff 2004 Jan; Suppl Web Exclusives:W4-259-61
HSL2390
Riggs DL, Holdsworth SM, McAvoy DR.
Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.249v1
HSL4712
Malavige GN.
Doctors, drug companies and medical ethics: a Sri Lankan perspective.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):26
HSL4713
Guha A.
A comparison of codes of pharmaceutical marketing practices.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):19-21
HSL4714
Dabade G.
Unhealthy drug donations.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):18
HSL4715
Bal A.
Can the medical profession and the pharmaceutical industry work ethically for better health care?
Indian J Med Ethics 2004 Jan-Mar; 1:(1):17
HSL4716
Gulhati CM.
Needed: closer scrutiny of clinical trials.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):4-5
HSL4717
Roy N.
Who rules the great Indian drug bazaar?
Indian J Med Ethics 2004 Jan-Mar; 1:(1):2-3
HSL7339
Winckler SC.
Drug importation: What's legal, what's safe? - APhA lays out the facts for pharmacists and their patients
Journal of the Pharmacy Society of Wisconsin 2004 Jan-Feb; 16-18
HSL7349
Berndt ER.
Perspective: Unique issues raised by drug benefit design.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):103-6
http://content.healthaffairs.org/cgi/content/full/23/1/103
HSL7350
Newhouse JP.
How much should Medicare pay for drugs?
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):89-102
http://content.healthaffairs.org/cgi/content/full/23/1/89
HSL7351
Pammolli F, Riccaboni M.
Perspective: Market structure and drug innovation.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):48-50
http://content.healthaffairs.org/cgi/content/full/23/1/48
HSL9735
Ghosh A, Hazra A, Mandal SC.
New drugs in India over the past 15 years: analysis of trends.
Natl Med J India 2004 Jan-Feb; 17:(1):10-6
HSL9766
Haynes SV, Dudderidge TJ.
Emergency contraception: the journey so far.
BJOG 2004 Jan; 111:(1):91
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1471-0528.2003.00020.x
HSL9777
Sellar PW.
Re: confusion between similarly named eye drops.
Eye 2004 Jan; 18:(1):111-2
http://www.nature.com/eye/journal/v18/n1/abs/6700570a.html;jsessionid=2F2DD8EC85EB55D8E0DCACA754334075
HSL9783
Mansour D, Trueman G.
Off-licence prescribing in contraception.
J Fam Plann Reprod Health Care 2004 Jan; 30:(1):9-10
http://www.popline.org/ics-wpd/exec/icswppro.dll?BU=http%3A%2F%2Fwww.popline.org%2Fics-wpd%2Fexec%2Ficswppro.dll&QF0=DocNo&QI0=186506&TN=Popline&AC=QBE_QUERY&MR=30&DL=1&&RL=1&&RF=LongRecordDisplay&DF=LongRecordDisplay
HSL9790
Evans L.
Prices, patents and productivity
Current Drug Discovery 2004 Jan; 33-35
HSL9989
Business Insights
Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share
: Business Insights 2004 Jan
http://www.piribo.com/publications/regulation_policy/harnessing_patient_power.html
HSL11461
Etemadi A, Raiszadeh F, Alaeddini F, Azizi F.
Views of Iranian medical journal editors on medical research publication.
Saudi Med J 2004 Jan; 25:(1):
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=14968189
HSL13325
Wright RF, Lundstrom WJ.
Physicians' perceptions of pharmaceutical sales representatives: A model for analysing the customer relationship
International Journal of Medical Marketing 2004 Jan; 4:(1):29-38
http://www.ingentaconnect.com/content/pal/jmm/2004/00000004/00000001/art00005
HSL16748
Tepper OM, Lurie PL, Wolfe SM
Medical Education Courses in Research-Based Health Activism
Virtual Mentor 2004 Jan; 6:1
HSL19516
Keim S, Perina DG
Council of Emergency Medicine Residency Directors Position on Interactions between Emergency Medicine Residencies and the Pharmaceutical Industry
Society for Academic Emergency Medicine 2004 Jan; 11:(1):78
http://onlinelibrary.wiley.com/doi/10.1197/j.aem.2003.05.011/abstract
HSL19800
Pammolli F, Riccaboni M
Perspective: Market Structure And Drug Innovation
Health Affairs 2004 Jan; 23:(1):48-50
http://content.healthaffairs.org/content/23/1/48.full
HSL19803
Hoadley JF
The Continued Need For Independent Research On Prescription Drugs
Health Affairs 2004 Jan; 23:(1):244-249
http://content.healthaffairs.org/content/23/1/244.abstract
HSL19804
Cockburn IM
The Changing Structure Of The Pharmaceutical Industry
Health Affairs 2004 Jan; 23:(1):10-22
http://content.healthaffairs.org/content/23/1/10.abstract
HSL19805
Campbell EG, Powers JB, Blumenthal D, Biles B
Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences
Health Affairs 2004 Jan; 23:(1):64-76
http://content.healthaffairs.org/content/23/1/64.abstract
HSL19806
Belsky L, Emanuel EJ
Conflicts of Interest and Presrving the Objectivity of Scientific Research
Health Affairs 2004 Jan; 23:(1):268-270
http://content.healthaffairs.org/content/23/1/268.full
HSL19927
Maignan I, Ferrell OC
Corporate Social Responsibility and Marketing: An Intergrative Framework
JAMS 2004 Jan; 32:(1):3-19
http://jam.sagepub.com/content/32/1/3.abstract
HSL19959
Croghan TW, Pittman PM
The Medicine Cabinet: What's In It, Why, And Can We Change The Contents?
Health Affairs 2004 Jan; 23:(1):23-33
http://content.healthaffairs.org/content/23/1/23.abstract
HSL19960
Kleinke JD
Access Versus Excess: Value-Based Cost Sharing For Prescription Drugs
Health Affairs 2004 Jan; 23:(1):34-47
http://content.healthaffairs.org/content/23/1/34.abstract
HSL19978
Priorities In The Pharmaceutical Industry
Health Affairs 2004 Jan; 23:(1):9
http://content.healthaffairs.org/content/23/1/9.full
HSL19979
Pauly MV
Medicare Drug Coverage and Moral Hazard
Health Affairs 2004 Jan; 23:(1):113-122
http://content.healthaffairs.org/content/23/1/113.abstract
HSL19980
Soumerai SB
Benefits and Risks of Increasing Restrictions on Access to Costly Drugs in Medicaid
Health Affairs 2004 Jan; 23:(1):135-146
HSL19987
Smith C
Retail Prescription Drug Spending in the National Health Accounts
Health Affairs 2004 Jan; 23:(1):160-167
http://content.healthaffairs.org/content/23/1/160.figures-only
HSL20364
Carpenter DP
The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy
Health Affairs 2004 Jan; 23:(1):52-63
http://content.healthaffairs.org/content/23/1/52.abstract
HSL357
Mansfield P, Henry D, Tonkin A.
Single-enantiomer drugs: elegant science, disappointing effects.
Clin Pharmacokinet 2004; 43:(5):287-90
http://www.ingentaconnect.com/content/adis/cpk/2004/00000043/00000005/art00002
HSL1148
Welch Cline RJ, Young HN.
Marketing drugs, marketing health care relationships: a content analysis of visual cues in direct-to-consumer prescription drug advertising.
Health Commun 2004; 16:(2):131-57
HSL1164
Szetela AM.
The relationship between health care and mass media in Polish law.
Med Law 2004; 23:(1):9-17
HSL1640
Collins K.
Profitable gifts: a history of the Merck Mectizan donation program and its implications for international health.
Perspect Biol Med 2004 Win; 47:(1):100-9
http://www.ncbi.nlm.nih.gov/pubmed/15061171
HSL1789
Baker D.
A free market solution for prescription drug crises.
Int J Health Serv 2004; 34:(3):517-26
HSL1796
Drug costs: research and development costs: the great illusion.
Prescrire Int. 2004; 13:(69):32-6
HSL1887
Huh J, DeLorme DE, Reid LN.
Media credibility and informativeness of direct-to-consumer prescription drug advertising.
Health Mark Q 2004; 21:(3):27-61
HSL1889
Kalb S.
[Influence of pharmaceutical advertising on the physician: A contribution to ethics in medicine].
Wurzbg Medizinhist Mitt 2004; 23:446-56:
HSL2048
Gardner H.
Changing Minds: The Art and Science of Changing Our Own Mind and Other People's Minds
Harvard: Harvard Business School Press 2004
http://harvardbusinessonline.hbsp.harvard.edu/b02/en/common/item_detail.jhtml;jsessionid=YKOILMM2CR4H2AKRGWDSELQ?id=7095
HSL2380
Edwards B.
Managing the interface with marketing to improve delivery of pharmacovigilance within the pharmaceutical industry.
Drug Saf. 2004; 27:(8):609-17
HSL2381
Goldman SA.
Communication of medical product risk: how effective is effective enough?
Drug Saf 2004; 27:(8):519-34
Page 117 of 144 pages ‹ First < 115 116 117 118 119 > Last ›
